SOM Biotech will attend the JP Morgan Healthcare Conference and Biotech Showcase Conference on January 13rd -15th 2020 – in San Francisco, USA.
Raul Insa – CEO and Maria Zimina – Business Development Manager of SOM Biotech – will be attending one-to-one meetings with qualified life science investors as well as other biotech and pharma companies “to share business development milestones and goals with potential business partners aiming at creating value leveraging on our pipeline and our AI-based molecule discovery technology SOM-PRO. We seek collaboration with strong partners with relevant expertise in drug development, specifically those really looking to strengthen their industrial expertise and internal portfolio to jointly develop major break-through therapies for patients with rare disorders mainly related to neurodegenerative diseases”.
The JP Morgan Healthcare Conference and Biotech Showcase are one of the industry´s most relevant investor conferences, where leading biotech and pharma companies, institutional investors, sell- and buy-side analysts, VCs and private equities meet to gain exclusive insights into investment and capital markets trends as well as biopharma innovation.
